Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Soleno Therapeutics (SLNO) Return on Equity (2016 - 2018)

Historic Return on Equity for Soleno Therapeutics (SLNO) over the last 5 years, with Q3 2018 value amounting to 0.04%.

  • Soleno Therapeutics' Return on Equity rose 1300.0% to 0.04% in Q3 2018 from the same period last year, while for Sep 2018 it was 0.04%, marking a year-over-year increase of 1300.0%. This contributed to the annual value of 0.05% for FY2018, which is 1900.0% up from last year.
  • Latest data reveals that Soleno Therapeutics reported Return on Equity of 0.04% as of Q3 2018, which was up 1300.0% from 0.09% recorded in Q2 2018.
  • In the past 5 years, Soleno Therapeutics' Return on Equity ranged from a high of 2.87% in Q3 2015 and a low of 12.58% during Q4 2015
  • Over the past 5 years, Soleno Therapeutics' median Return on Equity value was 0.14% (recorded in 2017), while the average stood at 1.13%.
  • As far as peak fluctuations go, Soleno Therapeutics' Return on Equity plummeted by -129300bps in 2015, and later surged by 109300bps in 2016.
  • Over the past 5 years, Soleno Therapeutics' Return on Equity (Quarter) stood at 0.35% in 2014, then crashed by -3728bps to 12.58% in 2015, then surged by 87bps to 1.66% in 2016, then soared by 91bps to 0.14% in 2017, then skyrocketed by 75bps to 0.04% in 2018.
  • Its last three reported values are 0.04% in Q3 2018, 0.09% for Q2 2018, and 0.11% during Q1 2018.